Company news and developments, with original sources and dates.
Updated from source·Oct 20, 2026, 18:05 UTC
On 2025/8/11, Forbes reported that biotechnology company Tahoe Therapeutics had raised USD 30 million at a USD 120 million valuation, bringing total funding to USD 42 million, with investment from Amplify Partners. It uses living-cell AI models to find new cancer treatments.